Early intestinal Th1 inflammation and mucosal T cell recruitment during acute graft-versus-host reaction

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 5991-5999

  Snider, Denis ^a   Liang, Hong ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

EID: 0035873678     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.5991     Document Type: Article

References (63)

1. Slavin, R. E., and G. W. Santos. 1973. The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin. Immunol. Immunopathol. 1:472.
2. Mowatt, A. 1997. Intestinal graft-versus-host disease. In Graft-Versus-Host Disease, 2nd Ed. J. L. M. Ferrara, H. J. Deeg. and S. J. Burakoff, eds. Marcel Dekker, New York, p. 338.
3. 1 mice. Clin. Exp. Immunol. 79:279.
4. Hakim, F. T., and C. L. Mackall. 1996. Immune system: effector and target of GVHD. In Graft-Versus-Host-Disease. 2nd Ed. J. L. M. Ferrara, H. J. Deeg, and S. J. Burakoff, eds. Marcel Dekker, New York, p. 257.
5. Garside, P., S. Reid, M. Steel, and A. M. Mowat. 1994. Differential cytokine production associated with distinct phases of murine graft-versus-host reaction. Immunology 82:211.
6. + T cells. J. Immunol. 155:2396.
7. Troutt, A. B., and A. Kelso. 1992. Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proc. Natl. Acad. Sci. USA 89:5276.
8. Allen, R. D., T. A. Staley, and C. L. Sidman. 1993. Differential cytokine expression in acute and chronic graft-versus-host-disease. Eur. J. Immunol. 23:333.
9. Mowat, A. M. 1989. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68:18.
10. Williamson, E., P. Garside, J. A. Bradley, I. A. More, and A. M. Mowat. 1997. Neutralizing IL-12 during induction of murine acute graft-versus host disease plarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. J. Immunol. 159:1208.
11. Williamson, E., P. Garside, J. A. Bradley, and A. M. Mowat. 1996. IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157:689.
12. 1-hybrid model using IFN-γ gene knockout donors. J. Immunol. 161:631.
13. Velardi, A., P. Varese, A. Terenzi, C. Dembech, N. Albi, C. E. Grossi, L. Moretta, M. F. Martelli, F. Grignani, and M. C. Mingari. 1989. Lymphokine production by T-cell clones after human bone marrow transplantation. Blood 74:1665.
14. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease. J. Exp. Med. 175:405.
15. Price, K. S., F. P. Nestel, and W. S. Lapp. 1997. Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease. Scand. J. Immunol. 45:294.
16. Piguet, P. F., G. E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166:1280.
17. Holler, E., H. J. Kolb, R. Hintermeier-Knabe, J. Mittermuller, S. Thierfelder, M. Kaul, and VV. Wilmanns. 1993. Role of tumor necrosis factor α in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant. Proc. 25:1234.
18. Holler, E., H. J. Kolb, A. Möller, J. Kempeni, S. Liesenfeld, H. Pechumer, W. Lehmacher, G. Ruckdeschel, B. Gleixner, and C. Riedner. 1990. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 75:1011.
19. Mowat, A. M., and M. V. Felstein. 1987. Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction. Immunology 61:179.
20. + cells of donor origin. Transplantation 45:586.
21. 1 hybrid mice with acute graft-versus-host disease. Transplantation 66:284.
22. Guy-Grand, D., and P. Vassalli. 1986. Gut injury in mouse graft-versus-host reaction: study of its occurrence and mechanisms. J. Clin. Invest. 77:1584.
23. Mowat, A. M., and A. Ferguson. 1982. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology 83:417.
24. Tsuzuki, T., Y. Yoshikai, M. Ito, N. Mori, M. Ohbayashi, and J. Asai. 1994. Kinetics of intestinal intraepithclial lymphocytes during acute graft-versus-host disease in mice. Eur. J. Immunol. 24:709.
25. Schaffeler, M. P., J. S. Brokenshire, and D. P. Snider. 1997. Detection of precursor Th cells in mesenteric lymph nodes after oral immunization with protein antigen and cholera toxin. Int. Immunol. 9:1555.
26. Snider, D. P., H. Liang, I. Switzer, and B. J. Underdown. 1999. IgA production in MHC class II-deficient mice is primarily a function of B-1a cells. Int. Immunol. 11:198.
27. Tagliabue, A., A. D. Befus, D. A. Clark, and J. Bienenstock. 1982. Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J. Exp. Med. 155:1785.
28. Sachs, D. H., N. Mayer, and K. Ozato. 1981. Hybridoma antibodies directed toward murine H-2 and la antigens. In Monoclonal Antibodies and T-Cell Hybridomas. J. Hammerling, U. Hammerling, and J. F. Kearney, eds. Elsevier/ North-Holland, New York, p. 95.
29. Snider, D. P. 1992. Immunization with antigen bound to bispecific antibody induces antibody that is restricted in epitope specificity and contains antiidiotype. J. Immunol. 148:1163.
30. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
31. Williams, M. B., and E. C. Butcher. 1997. Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen. J. Immunol. 159:1746.
32. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
33. Budd, R. C., J.-C. Cerottini, C. Horvath, C. Bron, T. Pedrazzine, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138:3120.
34. DeGrendele, H. C., M. Kosfiszer, P. Estess, and M. H. Siegelman. 1997. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol. 159:2549.
35. Huet, S., H. Groux, B. Caillou, H. Valentin, A.-M. Prieur, and A. Bernard. 1989. CD44 contributes to T cell activation. J. Immunol. 143:798.
36. Galandrini, R., N. Albi, G. Tripodi, D. Zarcone, A. Terenzi, A. Moretta, C. E. Grossi, and A. Velardi. 1993. Antibodies to CD44 trigger effector functions of human T cell clones. J. Immunol. 150:4225.
37. Shimizu, Y., and S. Shaw. 1991. Lymphocyte interactions with extracellular matrix. FASEB J. 5:2292.
38. 7. Scand. J. Immunol. 42:662.
39. Picker, L. J., R. J. Martin, A. Trumble, L. S. Newman, P. A. Collins. P. R. Bergstresser, and D. Y. M. Leung. 1994. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur. J. Immunol. 24:1269.
40. 7 integrins and memory differentiation. J. Immunol. 156:3727.
41. 7. Int. Immunol. 6:263.
42. Smith, S. R., C. Terminelli, L. Kenworthy-Bott, and D. L. Phillips. 1991. A study of cytokine production in acute graft-versus-host disease. Cell. Immunol. 134:336.
43. Husband, A. J., K. W. Beagley, and J.R. McGhee. 1999. Mucosal cytokines. In Mucosal Immunity. 2nd Ed. P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee, eds. Academic Press, San Diego, p. 541.
44. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
45. Romagnani, S. 1997. The Th1/Th2 paradigm. Immunol. Today 18:263.
46. Schoenbeck, S., D. T. McKenzie, and M. F. Kagnoff. 1989. Interleukin 5 is a differentiation factor for IgA B cells. Eur. J. Immunol. 19:965.
47. Harriman, G. R., D. Y. Kunimoto, J. F. Elliott, V. Paetkau, and W. Strober. 1988. The role of IL-5 in IgA B cell differentiation. J. Immunol. 140:3033.
48. Murray, P. D., D. T. McKenzie, S. L. Swain, and M. F. Kagnoff. 1987. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol. 139:2669.
49. Xu-Amano, J., W. K. Aicher, T. Taguchi, H. Kiyono, and J. R. McGhee. 1992. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 4:433.
50. Schreiber, S. 1997. Interleukin-10 in the intestine. Gut 41:274.
51. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
52. Macatonia, S. E., T. M. Doherty, S. C. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J. Immunol. 150:3755.
53. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
54. 4 integrins in gut mucosal injury of graft-versus-host disease. Int. Immunol. 7:1183.
55. Harriman, G. R., and W. Strober. 1987. Interleukin 5, a mucosal lymphokine? J. Immunol. 139:3553.
56. McGhee, J. R., J. Mestecky, C. O. Elson, and H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175.
57. + T cells that secrete IFN-γ and IL-5. J. Immunol. 145:68.
58. Roy, C., T. Ghayur, P. A. L. Kongshavn, and W. S. Lapp. 1982. Natural killer cell activity by spleen, lymph node, and thymus cells during the graft-versus-host reaction. Transplantation 34:144.
59. Ghayur, T., T. A. Seemayer, and W. S. Lapp. 1987. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction: relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Transplantation 44:354.
60. 1 mice injected with parental spleen cells. J. Immunol. 140:744.
61. Borland, A., A. M. Mowat, and D. M. V. Parrott. 1983. Augmentation of intestinal and peripheral natural killer cell activity during the graft-versus-host reaction in mice. Transplantation 36:513.
62. Lollini, P. L., A. D'Errico, C. De Giovanni, L. Landuzzi, F. Frabetti, G. Nicoletti, F. Cavallo, M. Giovarelli, W. F. Grigioni, and P. Nanni. 1995. Systemic effects of cytokines released by gene-transduced tumor cells: marked hyperplasia induced in small bowel by γ-interferon transfectants through host lymphocytes. Int. J. Cancer 61:425.
63. Adams. R. B., S. M. Planchon, and J. K. Roche. 1993. IFN-γ modulation of epithelial barrier function: time course, reversibility, and site of cytokine binding. J. Immunol. 150:2356.